Evotec announces first funded projects of translational BRIDGE beLAB1407 in collaboration with Bristol Myers Squibb

  • Evotec SE today announced the first two projects to be developed within beLAB1407, a collaboration between Evotec and Bristol Myers Squibb to accelerate translational research from the UK’s academic life science ecosystem. Only six months after signing the beLAB1407 collaboration agreement in May 2021, the first projects to be developed within this academic BRIDGE collaboration have now been identified. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-announces-first-funded-projects-of-translational-bridge-belab1407-in-collaboration-with-bristol-myers-squibb-6108

    Du magst vielleicht auch